UK140
UK140 is the inhibitor for urokinase-type plasminogen activator (uPA) with Ki of 0.20 µM and 2.79 µM for huPA anf muPA. UK140 can be used in metastasis-related research[1].
Product Specifications
UNSPSC
12352209
Target
PAI-1
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
O=C([C@@H](N)C)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N1[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(O)=O)=O)CSC2)=O)CO)=O)CO)=O)CCC1)=O)CC(O)=O)=O)C(C)C)=O)=O)CSC3)=O)=O)CO)=O)CC4=CC=CC=C4)=O)CCCCN)=O)CO)=O)CC(N)=O)=O)CSCC5=CC2=CC3=C5
Molecular Formula
C72H105N19O25S3
Molecular Weight
1732.91
References & Citations
[1]Mazzocato Y, et al., A novel genetically-encoded bicyclic peptide inhibitor of human urokinase-type plasminogen activator with better cross-reactivity toward the murine orthologue. Bioorg Med Chem. 2023 Nov 15;95:117499.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940040-500 1x 500 µL
CD35 / CR1 (E11), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471073-100 1x 100 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
